If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPz Cussons Regulatory News (PZC)

Share Price Information for Pz Cussons (PZC)

Share Price is delayed by 15 minutes
Get Live Data
108.20    5.00 (4.84%)
Bid:
107.80
Ask:
108.20
Spread: 0.40 (0.371%)
Market Cap: £454.82m
PZC Live PriceLast checked at - London Stock Exchange

Intraday Pz Cussons Share Chart

Update on Settlement Agreement with Former CEO

2 Apr 2020 07:00

RNS Number : 5040I
PZ CUSSONS PLC
02 April 2020
 

2 April 2020

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

PZ Cussons Plc

 

("PZ Cussons", the "Company" or the "Group")

 

Update on Settlement Agreement with Former Chief Executive Officer

 

Background

 

Following the announcement on 12 December 2019 of the retirement of the Chief Executive Officer Alex Kanellis on 31 January 2020, certain matters were brought to the attention of the Company. These related to a number of cash withdrawals and payments made by Mr Kanellis over a period of years. These actions had not previously been disclosed to the Board and, if substantiated, indicated behaviours inconsistent with what would be expected of a senior member of management.

 

As soon as it became aware of the alleged activities, the Board immediately initiated an independent investigation, led by external law firm Addleshaw Goddard LLP, which is now complete. A report has been presented to and considered by the PZ Cussons Board. The Board is now in a position to conclude that Mr Kanellis' conduct fell short of that which could reasonably be expected from the Chief Executive Officer and constituted repeated breaches of his duties as a Director of the Company. The Board is satisfied that the financial amounts involved are not material in the context of the Group and that there is no impact on or requirement to restate the financial statements for the current or any prior periods.

 

Settlement Agreement with Mr Kanellis

 

During the period of the investigation, Mr Kanellis (who had in the meantime been placed on garden leave) retired as previously announced. The settlement agreement between the Company and Mr Kanellis dated 11 December 2019 required certain representations to be reconfirmed by Mr Kanellis before payments due upon his retirement could be made. As a result of facts coming to light as part of this investigation, the Board believes that Mr Kanellis could not in the circumstances reconfirm those representations. As a consequence, the Remuneration Committee has determined that no payments will be made directly to Mr Kanellis in connection with his retirement.

 

An updated Section 430(2B) Companies Act 2006 Statement relating to remuneration payments to Mr Kanellis will be published in the Investors section of the Company's website.

 

Further Actions

 

As part of good governance, the Board has instructed a firm of independent accountants to perform a review of Controls and Compliance, focusing on specific areas highlighted by Addleshaw Goddard's report. This external review, and the Board's prompt actions in dealing with these conduct issues as soon as they were brought to its attention, emphasise the critical importance that the Board attaches to appropriate conduct across the entire Group.

 

The person responsible for arranging this announcement on behalf of PZ Cussons is Sam Plant, Corporate Services Director.

 

-Ends-

 

For further information contact:

 

Tim Linacre

Instinctif Partners

Telephone: 07949 939237

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCIBMBTMTIMTPM
Date   Source Headline
19th Jun 20262:59 pmRNSDirector/PDMR Shareholding
17th Jun 20267:00 amRNSTRADING UPDATE
20th May 20264:49 pmRNSDirector/PDMR Shareholding
21st Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20268:43 amRNSDirector/PDMR Shareholding
10th Apr 20264:01 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSQ3 TRADING UPDATE
19th Mar 20268:59 amRNSDirector/PDMR Shareholding
3rd Mar 20264:27 pmRNSDirector/PDMR Shareholding
19th Feb 202611:04 amRNSDirector/PDMR Shareholding
13th Feb 20263:32 pmRNSDirector/PDMR Shareholding
13th Feb 20262:21 pmRNSDirector/PDMR Shareholding
11th Feb 20267:01 amRNSCapital Markets Event
11th Feb 20267:00 amRNSInterim Results
22nd Jan 20263:00 pmRNSDirectorate change
20th Jan 20264:39 pmRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirectorate change
22nd Dec 20257:00 amRNSDirectorate change
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
18th Dec 20255:29 pmRNSDirector/PDMR Shareholding
15th Dec 20254:27 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSConclusion of Strategic Review of Africa
2nd Dec 20252:42 pmRNSDirector/PDMR Shareholding
28th Nov 20253:25 pmRNSDirector/PDMR Shareholding
20th Nov 20254:23 pmRNSResult of AGM
20th Nov 20257:00 amRNSAGM Trading Statement
19th Nov 20255:57 pmRNSDirector/PDMR Shareholding
21st Oct 20255:07 pmRNSDirector/PDMR Shareholding
1st Oct 20254:20 pmRNSDirector/PDMR Shareholding
1st Oct 20254:16 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSDirectorate Change
25th Sep 202512:06 pmRNSPublication of Annual Report and Notice of AGM
24th Sep 20253:56 pmRNSDirector/PDMR Shareholding
19th Sep 20255:03 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSFinal Results
20th Aug 20259:16 amRNSDirector/PDMR Shareholding
21st Jul 20255:07 pmRNSDirector/PDMR Shareholding
26th Jun 20257:00 amRNSUpdate on St. Tropez
19th Jun 20254:47 pmRNSDirector/PDMR Shareholding
18th Jun 20257:00 amRNSSale of Joint Venture and Trading Update
21st May 20254:49 pmRNSDirector/PDMR Shareholding
7th May 20253:29 pmRNSDirector Declaration
23rd Apr 20254:32 pmRNSDirector/PDMR Shareholding
10th Apr 20255:06 pmRNSDirector/PDMR Shareholding
19th Mar 20254:37 pmRNSDirector/PDMR Shareholding
19th Feb 202511:38 amRNSDirector/PDMR Shareholding
11th Feb 20257:00 amRNSInterim Results
21st Jan 202511:43 amRNSDirector/PDMR Shareholding
19th Dec 20244:24 pmRNSDirector/PDMR Shareholding
6th Dec 20243:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.